HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun-Shien Lee Selected Research

Adjuvant Chemotherapy

1/2018Genomic scar signatures associated with homologous recombination deficiency predict adverse clinical outcomes in patients with ovarian clear cell carcinoma.
10/2016Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun-Shien Lee Research Topics

Disease

32Neoplasms (Cancer)
12/2023 - 07/2006
10Infections
03/2024 - 08/2010
8Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 09/2014
7Hepatocellular Carcinoma (Hepatoma)
12/2021 - 06/2004
6Leukoplakia
06/2021 - 08/2009
6Oral Leukoplakia
01/2021 - 08/2009
5Ovarian Neoplasms (Ovarian Cancer)
12/2023 - 09/2010
5Squamous Cell Carcinoma of Head and Neck
09/2023 - 07/2010
5Pre-Eclampsia (Preeclampsia)
01/2022 - 03/2010
5Carcinoma (Carcinomatosis)
11/2021 - 05/2015
5Inflammation (Inflammations)
01/2017 - 07/2008
4Nasopharyngeal Carcinoma
01/2022 - 01/2008
4Endometriosis
11/2021 - 01/2012
4Carcinogenesis
12/2019 - 01/2008
3Adenomyosis
12/2023 - 01/2018
3Cicatrix (Scar)
08/2022 - 01/2019
3Allergic Rhinitis
11/2016 - 07/2008
3Neoplasm Metastasis (Metastasis)
10/2016 - 11/2008
3Hypoxia (Hypoxemia)
08/2012 - 01/2008
2Virus Diseases (Viral Diseases)
01/2024 - 08/2010
2Hypersensitivity (Allergy)
08/2022 - 01/2021
2Sinusitis
01/2022 - 03/2011
2Fibrosis (Cirrhosis)
01/2022 - 08/2011
2Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 03/2015
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2021
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2015
2Leukemia
02/2020 - 12/2019
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2020 - 11/2018
2Stroke (Strokes)
01/2018 - 01/2015
2Urinary Tract Infections (Urinary Tract Infection)
01/2015 - 01/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2014 - 01/2010
2Fetal Growth Retardation (Intrauterine Growth Retardation)
05/2011 - 03/2010
2Abscess
03/2011 - 01/2008
1Hypopharyngeal Neoplasms
09/2023
1Mitochondrial Diseases (Mitochondrial Disease)
02/2023
1Drug Hypersensitivity (Drug Allergy)
08/2022
1Exophthalmos (Proptosis)
07/2022
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2022
1AIDS-Related Complex (ARC)
01/2022
1Hypertrophy
01/2022

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
09/2021 - 03/2010
9DNA (Deoxyribonucleic Acid)IBA
07/2020 - 03/2008
7Biomarkers (Surrogate Marker)IBA
11/2021 - 11/2008
7Complementary DNA (cDNA)IBA
03/2015 - 06/2004
6RNA (Ribonucleic Acid)IBA
01/2021 - 07/2006
5Anti-Bacterial Agents (Antibiotics)IBA
07/2022 - 01/2008
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2022 - 11/2011
4PhosphoproteinsIBA
04/2018 - 09/2010
3Tumor Biomarkers (Tumor Markers)IBA
12/2023 - 09/2010
3HLA-B Antigens (HLA-B)IBA
08/2022 - 01/2019
3ParaffinIBA
12/2021 - 01/2010
3Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2012
3MicroRNAs (MicroRNA)IBA
09/2012 - 05/2010
2Antiviral Agents (Antivirals)IBA
01/2024 - 01/2020
2Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
09/2023 - 01/2021
2InflammasomesIBA
02/2023 - 01/2015
2Formaldehyde (Formol)FDA Link
12/2021 - 05/2010
2Glucose (Dextrose)FDA LinkGeneric
11/2021 - 11/2018
2Metalloproteases (Metalloproteinases)IBA
01/2021 - 09/2014
2Matrix Metalloproteinases (MMPs)IBA
01/2021 - 01/2015
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2021 - 01/2015
2hydrogen sulfite (bisulfite)IBA
07/2020 - 12/2010
2DNA Methyltransferase 3AIBA
02/2020 - 11/2018
2Tyrosine Kinase InhibitorsIBA
01/2020 - 09/2014
2ErbB Receptors (EGF Receptor)IBA
01/2019 - 09/2014
2activin AIBA
01/2019 - 07/2010
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2018 - 01/2015
2Indicators and Reagents (Reagents)IBA
01/2017 - 08/2009
2OligonucleotidesIBA
11/2016 - 03/2008
2CytokinesIBA
01/2015 - 11/2011
2Phosphotransferases (Kinase)IBA
09/2014 - 08/2012
2EndoglinIBA
09/2011 - 03/2010
2Transforming Growth Factor beta (TGF-beta)IBA
07/2010 - 01/2008
1Coloring Agents (Dyes)IBA
03/2024
1CatalaseIBA
03/2024
1Karyopherins (Importin)IBA
01/2024
1Viral ProteinsIBA
01/2024
1Peptides (Polypeptides)IBA
12/2023
1Genetic Markers (Genetic Marker)IBA
09/2023
1HLA Antigens (Human Leukocyte Antigens)IBA
08/2022
1DapsoneFDA Link
08/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2022
1Protons (Proton)IBA
01/2022
1CalciumIBA
01/2022
1PlasticsIBA
01/2022
1Angiotensin II Type 1 Receptor BlockersIBA
01/2022

Therapy/Procedure

9Therapeutics
12/2023 - 09/2014
7Gas Lasers
06/2021 - 06/2011
4Laser Therapy (Surgery, Laser)
01/2021 - 01/2010
3Lasers (Laser)
04/2018 - 01/2010
2Cell- and Tissue-Based Therapy (Cell Therapy)
12/2023 - 10/2014
2Hysterectomy
12/2023 - 07/2006
2Drug Therapy (Chemotherapy)
01/2021 - 01/2020
2Acupuncture Points (Acupuncture Point)
01/2019 - 11/2016
2Adjuvant Chemotherapy
01/2018 - 10/2016
2Endoscopes
05/2015 - 04/2014
2Acupuncture Therapy
01/2010 - 07/2008
1Immunotherapy
12/2023
1Radiotherapy
01/2022
1Proton Therapy
01/2022